Matches in SemOpenAlex for { <https://semopenalex.org/work/W103304032> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W103304032 abstract "Docetaxel has been the cornerstone in the treatment of castration- resistant prostate cancer (CRPC) since 2004. The recent and almost simultaneous arrival of new and effective molecules - several of which are already available on the market - has added to the CRPC treatment arsenal. Several studies have explored the optimal order in which these new treatments should be administered. The aim of this review was to present their respective predictive and evaluative factors and suggest potential administration sequences.The PubMed medical literature citations database was searched using the following key words: prostate cancer, castration resistant, metastatic, targeted therapy, treatment sequence, immunotherapy and clinical trials. The reports of the most recent European and North American congresses were also included.While no predictive factors have been clearly identified for these new therapies to date, a Gleason score of not less than 8 and one or more chemotherapy sessions seemed to be predictive of lower efficacy for abiraterone. Promising elements for further investigation include the circulating tumour cell count and variation in this count per treatment, ERG mutation status or the intratumoural androgen status. Substitution criteria have not yet been reported but, as is the case with all hormone therapies, changes in PSA levels emerge as a valuable indicator of the efficacy of abiraterone. The best treatment sequence for patients who develop castration-resistance remains to be defined.Although new molecules have recently become available, the experience with their use is limited. Thus, no predictive markers of response rates and treatment outcomes or data concerning the best treatment sequence to use in patients with CRPC are as yet available." @default.
- W103304032 created "2016-06-24" @default.
- W103304032 creator A5016153087 @default.
- W103304032 creator A5028972854 @default.
- W103304032 creator A5080354002 @default.
- W103304032 creator A5088072625 @default.
- W103304032 date "2013-10-01" @default.
- W103304032 modified "2023-09-30" @default.
- W103304032 title "Choix des nouveaux traitements médicaux dans le cancer de la prostate résistant à la castration: marqueurs prédictifs et évaluation de l’effi cacité" @default.
- W103304032 cites W1607353937 @default.
- W103304032 cites W1889335195 @default.
- W103304032 cites W2016006304 @default.
- W103304032 cites W2018083632 @default.
- W103304032 cites W2038932619 @default.
- W103304032 cites W2044287047 @default.
- W103304032 cites W2059381583 @default.
- W103304032 cites W2068744546 @default.
- W103304032 cites W2080134152 @default.
- W103304032 cites W2080439368 @default.
- W103304032 cites W2080798348 @default.
- W103304032 cites W2088318211 @default.
- W103304032 cites W2110534364 @default.
- W103304032 cites W2112564453 @default.
- W103304032 cites W2114281628 @default.
- W103304032 cites W2116458141 @default.
- W103304032 cites W2120292596 @default.
- W103304032 cites W2123526148 @default.
- W103304032 cites W2131456094 @default.
- W103304032 cites W2132850027 @default.
- W103304032 cites W2142466432 @default.
- W103304032 cites W2148643283 @default.
- W103304032 cites W2158176392 @default.
- W103304032 cites W2161193168 @default.
- W103304032 cites W2169737508 @default.
- W103304032 cites W2244473630 @default.
- W103304032 cites W2589802334 @default.
- W103304032 cites W2601357387 @default.
- W103304032 cites W2886226330 @default.
- W103304032 cites W3003729825 @default.
- W103304032 doi "https://doi.org/10.1016/s1166-7087(13)70045-9" @default.
- W103304032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24314738" @default.
- W103304032 hasPublicationYear "2013" @default.
- W103304032 type Work @default.
- W103304032 sameAs 103304032 @default.
- W103304032 citedByCount "1" @default.
- W103304032 countsByYear W1033040322015 @default.
- W103304032 crossrefType "journal-article" @default.
- W103304032 hasAuthorship W103304032A5016153087 @default.
- W103304032 hasAuthorship W103304032A5028972854 @default.
- W103304032 hasAuthorship W103304032A5080354002 @default.
- W103304032 hasAuthorship W103304032A5088072625 @default.
- W103304032 hasConcept C121608353 @default.
- W103304032 hasConcept C126322002 @default.
- W103304032 hasConcept C143998085 @default.
- W103304032 hasConcept C2775832370 @default.
- W103304032 hasConcept C2776421732 @default.
- W103304032 hasConcept C2776694085 @default.
- W103304032 hasConcept C2777899217 @default.
- W103304032 hasConcept C2780192828 @default.
- W103304032 hasConcept C2781190966 @default.
- W103304032 hasConcept C29456083 @default.
- W103304032 hasConcept C61367390 @default.
- W103304032 hasConcept C71924100 @default.
- W103304032 hasConceptScore W103304032C121608353 @default.
- W103304032 hasConceptScore W103304032C126322002 @default.
- W103304032 hasConceptScore W103304032C143998085 @default.
- W103304032 hasConceptScore W103304032C2775832370 @default.
- W103304032 hasConceptScore W103304032C2776421732 @default.
- W103304032 hasConceptScore W103304032C2776694085 @default.
- W103304032 hasConceptScore W103304032C2777899217 @default.
- W103304032 hasConceptScore W103304032C2780192828 @default.
- W103304032 hasConceptScore W103304032C2781190966 @default.
- W103304032 hasConceptScore W103304032C29456083 @default.
- W103304032 hasConceptScore W103304032C61367390 @default.
- W103304032 hasConceptScore W103304032C71924100 @default.
- W103304032 hasLocation W1033040321 @default.
- W103304032 hasLocation W1033040322 @default.
- W103304032 hasOpenAccess W103304032 @default.
- W103304032 hasPrimaryLocation W1033040321 @default.
- W103304032 hasRelatedWork W122177069 @default.
- W103304032 hasRelatedWork W2076767584 @default.
- W103304032 hasRelatedWork W2762424895 @default.
- W103304032 hasRelatedWork W2912565296 @default.
- W103304032 hasRelatedWork W2935114107 @default.
- W103304032 hasRelatedWork W2982156914 @default.
- W103304032 hasRelatedWork W2995842863 @default.
- W103304032 hasRelatedWork W3033741808 @default.
- W103304032 hasRelatedWork W3163358397 @default.
- W103304032 hasRelatedWork W3179582685 @default.
- W103304032 isParatext "false" @default.
- W103304032 isRetracted "false" @default.
- W103304032 magId "103304032" @default.
- W103304032 workType "article" @default.